CDX2

You have access
The Ovarian Portal: An Unusual Pathway to Discovery, A Rare Initial Manifestation of Colon Cancer
NASIM SALIMIAGHDAM, XUEBIN YANG and HONGYAN LIANG

Anticancer Research May 2026, 46 (5) 2915-2923; DOI: https://doi.org/10.21873/anticanres.18169
You have access
Knockdown of CDX2 Induces microRNA-221 Up-regulation in Human Colon Cancer Cells
JUNKO MUKOHYAMA, MINORI KOIZUMI, KIMIHIRO YAMASHITA, AKIHIDE YOSHIMI, DAI SHIDA and YOSHIHIRO KAKEJI

Anticancer Research August 2024, 44 (8) 3553-3556; DOI: https://doi.org/10.21873/anticanres.17177
You have access
CDX2 Is a Prognostic Biomarker for Unresectable Metastatic Colorectal Cancer
JUNKO MUKOHYAMA, KYOSUKE AGAWA, KIMIHIRO YAMASHITA, TAKERU MATSUDA, MASAHIRO SHINODA, OSAMU ITANO and YOSHIHIRO KAKEJI

Anticancer Research August 2023, 43 (8) 3763-3767; DOI: https://doi.org/10.21873/anticanres.16561
You have access
Double Negativity for Expression of YAP1 and CDX2 Defines an Aggressive Type of Colitis-associated Cancer
FENG YIN, HAO XIE, JINPING LAI, YUANHONG CHEN, JIXIN DONG, XUEFENG ZHANG and XIULI LIU

Anticancer Research October 2020, 40 (10) 5411-5416; DOI: https://doi.org/10.21873/anticanres.14550
You have access
Expression Pattern of CDX2, Estrogen and Progesterone Receptors in Primary Gastroenteropancreatic Neuroendocrine Tumors and Metastases
NADINE ZIMMERMANN, PAMELA LAZAR-KARSTEN, TOBIAS KECK, FRANCK BILLMANN, SEBASTIAN SCHMID, GEORG BRABANT and CHRISTOPH THORNS

Anticancer Research March 2016, 36 (3) 921-924;

Main menu